celecoxib has been researched along with phosphatidylcholines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dial, EJ; Lichtenberger, LM; Romero, JJ | 1 |
| Banerjee, S; Sade, A; Severcan, F | 1 |
| Danino, D; Kesselman, E; Magdassi, S; Margulis-Goshen, K | 1 |
| Banerjee, S; Erdoğ, A; Keskin, D; Putra Limasale, YD; Tezcaner, A | 1 |
| El-Badry, M; Fathalla, D; Fetih, G | 1 |
| Bauer-Brandl, A; Brandl, M; Elvang, PA; Jacobsen, AC; Stein, PC | 1 |
6 other study(ies) available for celecoxib and phosphatidylcholines
| Article | Year |
|---|---|
Surface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirin.
Topics: Animals; Aspirin; Celecoxib; Cyclooxygenase Inhibitors; Dinoprostone; Drug Interactions; Gastric Mucosa; Hydrophobic and Hydrophilic Interactions; Male; Phosphatidylcholines; Pyrazoles; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sulfonamides | 2007 |
Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Celecoxib; Drug Carriers; Drug Delivery Systems; Liposomes; Nephelometry and Turbidimetry; Phosphatidylcholines; Pyrazoles; Sulfonamides; Temperature | 2010 |
Formation of celecoxib nanoparticles from volatile microemulsions.
Topics: Acetates; Butanols; Celecoxib; Chemistry, Pharmaceutical; Cryoelectron Microscopy; Cyclooxygenase 2 Inhibitors; Drug Carriers; Drug Compounding; Electric Conductivity; Emulsions; Glycyrrhizic Acid; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Phosphatidylcholines; Powders; Pyrazoles; Solubility; Sulfonamides; Surface-Active Agents; Technology, Pharmaceutical; Volatilization; Water | 2010 |
In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
Topics: Celecoxib; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Cholesterol; Colorectal Neoplasms; Drug Delivery Systems; HCT116 Cells; HT29 Cells; Humans; Liposomes; Phosphatidylcholines; Polyethylene Glycols; Pyrazoles; Sulfonamides | 2013 |
Liposomal gels for site-specific, sustained delivery of celecoxib: in vitro and in vivo evaluation.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Celecoxib; Cholesterol; Drug Compounding; Edema; Gels; Liposomes; Particle Size; Phosphatidylcholines; Pyrazoles; Rats; Rats, Wistar; Sulfonamides | 2014 |
Co-existing colloidal phases in artificial intestinal fluids assessed by AF4/MALLS and DLS: A systematic study into cholate & (lyso-) phospholipid blends, incorporating celecoxib as a model drug.
Topics: Celecoxib; Colloids; Digestion; Drug Compounding; Dynamic Light Scattering; Fractionation, Field Flow; Glycodeoxycholic Acid; Intestinal Secretions; Lasers; Lysophosphatidylcholines; Micelles; Phosphatidylcholines; Scattering, Radiation; Solubility; Surface-Active Agents; Taurocholic Acid; Technology, Pharmaceutical | 2018 |